FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013316384> ?p ?o ?g. }

• W2013316384 endingPage "737.e24" @default.
• W2013316384 startingPage "737.e11" @default.
• W2013316384 abstract "The aim of this study was to explore the prognostic role of serum uric acid (UA) measurement in the hospital and long-term mortality assessment in subjects with acute heart failure (AHF) from the Acute HEart FAilure Database registry (AHEAD). The AHEAD registry comprised 4153 patients with AHF syndromes hospitalized at the AHEAD participating centers. The study included 1255 patients who were admitted to the AHEAD participating centers with acute decompensated chronic heart failure, de novo heart failure, or cardiogenic shock between September 2006 and October 2009 and who had information about serum UA concentration available at the time of hospital admission. The hospital and long-term mortality was followed using the centralized database of the Ministry of Health, Czech Republic. The mean age of the cohort was 73.4 years, the female population represented 43%, the median hospital stay was 8 days, and the mean hospital mortality was 7.6%. The median UA concentration of the patients with AHF was 432 μmol/L (7.26 mg/dL), the median estimated glomerular filtration rate (eGFR) was 49.0 mL/min, and N-terminal pro–brain natriuretic peptide level was 5510 pg/mL. Among other laboratory variables, UA concentration greater than 515 μmol/L (8.67 mg/dL) was associated with increased hospital mortality (P < .001), as well as eGFR less than 30 mL/min (P < .001), Na 135 mmol/L or less, and positive troponin. Uric acid concentration greater than 500 μmol/L (8.41 mg/dL) was associated with increased long-term mortality (P < .001), followed by eGFR less than 30 mL/min (P < .001), Na 135 mmol/L or less, and hemoglobin level lower than 130 g/L (P < .001). The 1-year survival rate of patients discharged from hospital (n = 1159) was 75.6%, and the 2-year rate was 66.8%. Survival of patients treated with allopurinol for hyperuricemia was significantly lower compared with untreated subjects (70.1 vs 77.2 for 1-year survival and 60.3 vs 68.5 for 2-year survival). In patients with AHF, increased UA levels and documented allopurinol therapy for hyperuricemia were associated with increased hospital and long-term mortality. Allopurinol therapy is not a cause but the identifier of the subjects at risk." @default.
• W2013316384 created "2016-06-24" @default.
• W2013316384 creator A5004104973 @default.
• W2013316384 creator A5005654087 @default.
• W2013316384 creator A5018080059 @default.
• W2013316384 creator A5035374413 @default.
• W2013316384 creator A5038262324 @default.
• W2013316384 creator A5043576007 @default.
• W2013316384 creator A5044693037 @default.
• W2013316384 creator A5049148310 @default.
• W2013316384 creator A5057430356 @default.
• W2013316384 creator A5071148307 @default.
• W2013316384 creator A5075282771 @default.
• W2013316384 creator A5077415534 @default.
• W2013316384 creator A5087589618 @default.
• W2013316384 date "2012-12-01" @default.
• W2013316384 modified "2023-10-18" @default.
• W2013316384 title "Uric acid, allopurinol therapy, and mortality in patients with acute heart failure—results of the Acute HEart FAilure Database registry" @default.
• W2013316384 cites W1414418298 @default.
• W2013316384 cites W1550111394 @default.
• W2013316384 cites W1695462328 @default.
• W2013316384 cites W1977110551 @default.
• W2013316384 cites W1979437297 @default.
• W2013316384 cites W2013125208 @default.
• W2013316384 cites W2027183986 @default.
• W2013316384 cites W2043031422 @default.
• W2013316384 cites W2053743696 @default.
• W2013316384 cites W2094456585 @default.
• W2013316384 cites W2116428665 @default.
• W2013316384 cites W2117489997 @default.
• W2013316384 cites W2127501869 @default.
• W2013316384 cites W2130198700 @default.
• W2013316384 cites W2133923391 @default.
• W2013316384 cites W2144308706 @default.
• W2013316384 cites W2144907361 @default.
• W2013316384 cites W2145612945 @default.
• W2013316384 cites W2147978034 @default.
• W2013316384 cites W2148082508 @default.
• W2013316384 cites W2159689950 @default.
• W2013316384 cites W2164032217 @default.
• W2013316384 cites W2187400291 @default.
• W2013316384 doi "https://doi.org/10.1016/j.jcrc.2012.03.011" @default.
• W2013316384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22699032" @default.
• W2013316384 hasPublicationYear "2012" @default.
• W2013316384 type Work @default.
• W2013316384 sameAs 2013316384 @default.
• W2013316384 citedByCount "37" @default.
• W2013316384 countsByYear W20133163842013 @default.
• W2013316384 countsByYear W20133163842014 @default.
• W2013316384 countsByYear W20133163842015 @default.
• W2013316384 countsByYear W20133163842016 @default.
• W2013316384 countsByYear W20133163842017 @default.
• W2013316384 countsByYear W20133163842019 @default.
• W2013316384 countsByYear W20133163842020 @default.
• W2013316384 countsByYear W20133163842021 @default.
• W2013316384 countsByYear W20133163842022 @default.
• W2013316384 crossrefType "journal-article" @default.
• W2013316384 hasAuthorship W2013316384A5004104973 @default.
• W2013316384 hasAuthorship W2013316384A5005654087 @default.
• W2013316384 hasAuthorship W2013316384A5018080059 @default.
• W2013316384 hasAuthorship W2013316384A5035374413 @default.
• W2013316384 hasAuthorship W2013316384A5038262324 @default.
• W2013316384 hasAuthorship W2013316384A5043576007 @default.
• W2013316384 hasAuthorship W2013316384A5044693037 @default.
• W2013316384 hasAuthorship W2013316384A5049148310 @default.
• W2013316384 hasAuthorship W2013316384A5057430356 @default.
• W2013316384 hasAuthorship W2013316384A5071148307 @default.
• W2013316384 hasAuthorship W2013316384A5075282771 @default.
• W2013316384 hasAuthorship W2013316384A5077415534 @default.
• W2013316384 hasAuthorship W2013316384A5087589618 @default.
• W2013316384 hasConcept C126322002 @default.
• W2013316384 hasConcept C159641895 @default.
• W2013316384 hasConcept C164705383 @default.
• W2013316384 hasConcept C179755657 @default.
• W2013316384 hasConcept C2776850375 @default.
• W2013316384 hasConcept C2778198053 @default.
• W2013316384 hasConcept C2779295919 @default.
• W2013316384 hasConcept C2779881121 @default.
• W2013316384 hasConcept C2908647359 @default.
• W2013316384 hasConcept C41008148 @default.
• W2013316384 hasConcept C500558357 @default.
• W2013316384 hasConcept C71924100 @default.
• W2013316384 hasConcept C72563966 @default.
• W2013316384 hasConcept C77088390 @default.
• W2013316384 hasConcept C99454951 @default.
• W2013316384 hasConceptScore W2013316384C126322002 @default.
• W2013316384 hasConceptScore W2013316384C159641895 @default.
• W2013316384 hasConceptScore W2013316384C164705383 @default.
• W2013316384 hasConceptScore W2013316384C179755657 @default.
• W2013316384 hasConceptScore W2013316384C2776850375 @default.
• W2013316384 hasConceptScore W2013316384C2778198053 @default.
• W2013316384 hasConceptScore W2013316384C2779295919 @default.
• W2013316384 hasConceptScore W2013316384C2779881121 @default.
• W2013316384 hasConceptScore W2013316384C2908647359 @default.
• W2013316384 hasConceptScore W2013316384C41008148 @default.
• W2013316384 hasConceptScore W2013316384C500558357 @default.
• W2013316384 hasConceptScore W2013316384C71924100 @default.
• W2013316384 hasConceptScore W2013316384C72563966 @default.

• next